AYUB S42 extraction and fractionation is evidence based, bioassay guided. All variables to be considered from geographical source, climate factor, harvest parameters, pre-processing, and extraction tuning.
Next, and based on preliminary data, further testing for possible synergism among plants under investigation to be determined and verified.

Boswellia species comparative Bioassay

Boswellia species essential oils comparative bioassay on J82 bladder cancer cell line and UROtsa normal immortalized bladder cells.

B. carteri essential oil bladder bioassay

Normal (UROtsa) and cancerous (J82) bladder cells viability under different titres of B. carteri essential oil

B. sacra essential oil bladder bioassay

Normal (UROtsa) and cancerous (J82) bladder cells viability under different titres of B. sacra essential oil

B. frereana essential oil bladder bioassay

Normal (UROtsa) and cancerous (J82) bladder cells viability under different titres of B. frereana essential oil

Boswellia sacra essential oil comparative bioassay

Boswellia sacra essential oil bioassay on breast, pancreatic and colorectal cancer cell lines

B. sacra essential oil - Colorectal Ca

B. sacra essential oil titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. sacra essential oil bioassay Pancreatic cancer cell lines bioassay

B. sacra essential oil IC50 & LC50, Pancreatic cancer cell lines. X: Volumetric titer, Y: Pancreatic cancer cell lines

B. Sacra essential oil - Breast Ca

B. sacra essential oil titers against 3 breast cancer cell lines (MDA-MB-231, MCF7, and T47D) and normal immortalized breast cells (MCF10-2A). X: Volumetric titer, Y: Cell line survival.

Boswellia sacra distillation fractions bioassay

B. Sacra essential oil potency per distillation time, Pancreatic Ca Cell lines

X: Volumetric dilution, Y:IC50

Geographical influence on B. Sacra essential oil Bioassay

B. sacra essential oil, West Dhofar, bioassay

B. sacra essential oil - West Dhofar, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. sacra essential oil, East Dhofar, bioassay

B. sacra essential oil - East Dhofar, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

Boswellia sacra Grades Bioassay Variation

B. Sacra Essential Oil - Green Grade, Colorectal Ca

B. sacra essential oil, Green Grade, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. sacra essential oil - Najdi Grade, Colorectal Ca bioassay

B. sacra essential oil, Najdi Grade, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. Sacra Hougari Grade enriched essential oil Bioassay

Enriched B. sacra essential oil, Hougari Grade, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. Sacra Green Grade enriched essential oil Bioassay

Enriched B. sacra essential oil, Green Grade, titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

B. Sacra enrichment evolution

B. sacra enriched essential oil titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival. 1/6500 titers.

Boswellia sacra essential oil - AYUB 00 - Colorectal Ca

B. sacra essential oil titers against 3 colorectal cancer cell lines (HCT116, SGW480, and HT29) and normal immortalized fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

AYUB 15 Bioassay, Breast Ca

Enriched B. sacra essential oil (A15) titers against 3 breast cancer cell lines (MDA-MB-231, MCF7, and T47D) and normal immortalized breast cells (MCF10-2A). X: Volumetric titer, Y: Cell line survival.

AYUB 16 Bioassay, Colorectal Ca

Enriched B. sacra essential oil (AYUB16) bioassay against 3 colorectal cancer cell lines (HCT116, SW480, and HT29) and immortalized normal fetal colorectal cells (FHC). X: Volumetric titer, Y: Cell line survival.

AYUB 15F Bioassay, Breast Ca

Tuned and Enriched B. sacra essential oil titers against 3 breast cancer cell lines (MDA-MB-231, MCF7, and T47D) and normal immortalized breast cells (MCF10-2A). X: Volumetric titer, Y: Cell line survival.

AYUB HSF Bioassay, Breast Ca

Tuned Enriched B. sacra essential oil titers against 3 breast cancer cell lines (MDA-MB-231, MCF7, and T47D) and normal immortalized breast cells (MCF10-2A). X: Volumetric titer, Y: Cell line survival.

Boswellia sacra essential oil hydro-sonic fractionation

AYUB HSF , Bladder Bioassay

AYUB E Breast Bioassay

Commiphora myrrha essential oil Bioassay, Breast Ca

MCF10-2A (Normal Immortalized Breast cells), MCF7 and T47D (Breast Cancer cell lines) response to Commiphora myrrha essential oil

C. Myrrha HSF Bioassay, T47D Breast Ca

Tuned C. myrrha essential oil HSF C. myrrha, Arabian and African essential oil, titers against T47D breast ca cell line. X: Volumetric titer, Y: Cell line survival.

C. myrrha essential oil, from Arabia and Africa, Breast Ca Bioassay

C. myrrha, Arabian and African essential oil, titers against 3 breast cancer cell lines (MDA-MB-231, MCF7, and T47D) and normal immortalized breast cells (MCF10-2A). X: Volumetric titer, Y: Cell line survival.

Nigella sativa essential oil on bladder cancer

Nigella sativa essential oil, 4 extraction methods, on J82 Bladder cancer cell line

Nigella sativa essential oil UROtsa cell line

Nigella sativa - Boswellia sacra essential oils synergism

Nigella sativa - Boswellia sacra essential oils combination on J82 Bladder cancer cell line